Search - tctmd.com

Displaying 201 - 220 of 1847

Sort: Relevancy | Date

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Putting It All Together: A Case of TTVR

Presenter: Karl-Philipp Rommel

February 12, 2025

Presentation THT 2025

TTVI Trial Updates

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT 2025

Emerging Questions in the Face of Multiple Effective Therapies

Presenter: Matthew Maurer

February 11, 2025

Presentation THT 2025

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Presenter: Mazen Hanna

February 11, 2025

Presentation THT 2025

Anti-Amyloid Therapy – Will Depleters Change the Game?

Presenter: Scott Solomon

February 11, 2025

Presentation THT 2025

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Presenter: Ahmad Masri

February 11, 2025

Presentation THT 2025

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Presenter: Giada Bianchi

February 11, 2025

Presentation THT 2025

Stabilizers for TTR Amyloidosis: Is One Better Than Another

Presenter: Jan Griffin

February 11, 2025

Presentation TCT 2024

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

Presenter: Daniel Mitchell

October 30, 2024

Presentation TCT 2024

TCT 717: Prognostic Implications of Residual Global Quantitative Flow Ratio in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Presenter: Zaid Abdulelah

October 30, 2024

Presentation TCT 2024

Case Presentation 1: Complex Barlow's Disease in a High Surgical Risk Patient

Presenter: Mathew Williams

October 30, 2024

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

TCT 802: Every Heart Matters: A Local Initiative of Screening for Valvular Heart Disease in Western Pennsylvania

Presenter: Anita Radhakrishnan

October 30, 2024

Presentation TCT 2024

TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease

Presenter: Junaid Mir

October 30, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

Presentation TCT 2024

Creative Uses of AI in Imaging for Structural Heart Disease

Presenter: Partho Sengupta

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

Advertisement

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Putting It All Together: A Case of TTVR

TTVI Trial Updates

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Emerging Questions in the Face of Multiple Effective Therapies

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Anti-Amyloid Therapy – Will Depleters Change the Game?

Silencing TTR With Drugs or CRISPR: Benefits and Risks

Novel Therapies for AL Cardiac Amyloidosis – Bi-Specific Antibodies, BCL Inhibitors and More

Stabilizers for TTR Amyloidosis: Is One Better Than Another

TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis

TCT 717: Prognostic Implications of Residual Global Quantitative Flow Ratio in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Case Presentation 1: Complex Barlow's Disease in a High Surgical Risk Patient

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

TCT 802: Every Heart Matters: A Local Initiative of Screening for Valvular Heart Disease in Western Pennsylvania

TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Creative Uses of AI in Imaging for Structural Heart Disease

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content